The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,565.00
Bid: 3,560.00
Ask: 3,570.00
Change: 15.00 (0.42%)
Spread: 10.00 (0.281%)
Open: 3,520.00
High: 3,570.00
Low: 3,520.00
Prev. Close: 3,550.00
CLDN Live PriceLast checked at -
Caledonia is an Investment Trust

To grow net assets and dividends over the long term, whilst managing risk to avoid permanent loss of capital.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

29 Jun 2017 15:01

RNS Number : 6265J
Caledonia Investments PLC
29 June 2017
 

 

 

 

 

CALEDONIA INVESTMENTS PLC

 

REDUCTION OF HOLDING IN COBEHOLD SA

 

Caledonia Investments plc ("Caledonia") announces that it has today reduced its holding in Cobehold SA ("Cobehold"), the holding company of Cobepa SA, the Belgian unquoted investment company, from 8.7% to 5.4%, realising €58.2m. As a result of a forward foreign exchange contract previously put in place to hedge the proceeds from the anticipated sale, Caledonia will receive £50.6m.

 

The sale was effected through an annual internal trading round operated by Cobehold and all of the shares sold were therefore taken up by other Cobehold shareholders. Caledonia's remaining 5.4% stake in Cobehold is valued at €93.2m (£81.8m). The sale price was based on the same local currency valuation of Cobehold as used for Caledonia's reported net asset value as at 31 March 2017.

 

Commenting on the sale, Will Wyatt, Caledonia's Chief Executive, said:

 

"Caledonia has been a shareholder in Cobehold since 2004. Its success over the past thirteen years has contributed to Cobehold now being our largest investment and today's sale has been undertaken to adjust its balance within Caledonia's unquoted portfolio. We remain a supportive shareholder in the company and are confident that its strong management team and distinctive investment approach, which is focused on long term value creation and very much complements our own business model, will continue to deliver rewards for Caledonia."

 

 29 June 2017

For further information contact:

 

 

Caledonia Investments plc

Will Wyatt,

Chief Executive

 

Stephen King

Finance Director

+44 20 7802 8080

Duncan Johnson,

Head of Unquoted Investments

Media contact:

Tulchan Communications

Peter Hewer

+44 20 7353 4200

 

END

 

 

 

Notes for editors:

 

Caledonia Investments plc

 

Caledonia is a self-managed investment trust company listed on the London Stock Exchange with net assets of approximately £1.9bn as at 31 May 2017. The company maintains a concentrated portfolio of international quoted, unquoted and fund investments and has paid an increasing annual dividend for 50 years.

 

In the unquoted arena, Caledonia seeks to invest £25m to £100m in private companies either on a majority or minority basis, providing a meaningful presence and growth capital supporting double-digit operating margins. Its current unquoted portfolio includes Cobehold (a European unquoted investment house), Gala Bingo (the UK market leading retail bingo operator), Seven Investment Management (a provider of discretionary fund management, asset management and self-invest platform services), Liberation Group (the market leading Channel Islands pub, restaurants and drinks business), The Sloane Club (a London residential club) and Choice Care Group (a UK learning disability care homes provider).

 

For additional information on Caledonia, please visit www.caledonia.com.

 

Cobehold

 

Cobehold is the holding company of Cobepa SA, an independent, privately-held investment company with a net worth of approximately €2bn. Cobepa started its investment activities in Belgium in 1957 as a dedicated subsidiary of Banque Paribas, but has operated as an independent investment company since 2004, investing in the private equity arena throughout Europe. It now has offices in Brussels and New York.

 

Cobepa's investment approach is centred on two main types of investment:

 

· Growth capital investments, in which Cobepa takes significant minority stakes;

 

· Buy-out transactions, in which Cobepa acquires control or co-control of the company alongside the management and other investors.

 

Cobepa aims to contribute actively to the development of each of its portfolio companies, leveraging upon its know-how, experience and business network in order to facilitate and support value-creating strategies through close working relationships with management.

 

For additional information on Cobepa, please visit www.cobepa.com.

 

 

 

Neither the contents of Caledonia's or Cobepa's websites, nor the contents of any website accessible from hyperlinks on such websites (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISXKLFLDQFEBBD
Date   Source Headline
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding
6th Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 20233:23 pmRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSDirectorate Change
23rd May 20237:00 amRNSFinal Results
9th May 20232:16 pmRNSNet Asset Value(s)
20th Apr 20239:40 amRNSAcquisition
12th Apr 202310:42 amRNSResponse to press speculation
11th Apr 20237:00 amRNSUnaudited net asset value and portfolio update
28th Mar 20231:50 pmRNSDirectorate Change
22nd Mar 20235:04 pmRNSDirector/PDMR Shareholding
14th Mar 20235:35 pmRNSDirector/PDMR Shareholding
6th Mar 20232:18 pmRNSNet Asset Value(s)
6th Feb 202311:47 amRNSNet Asset Value(s)
9th Jan 20237:00 amRNSUnaudited net asset value and portfolio update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.